Qorvis

08/26/2026

We can't escape the onslaught of AI-generated content, misinformation, and entirely fabricated "news" in our feeds. And due to information laundering, it is getting harder to verify claims and distinguish misinformation from legitimate reporting.

But while the content itself may be difficult to verify, the path it takes is harder to fake. Misinformation leaves fingerprints.

In the latest in the Qorvis series on misinformation, our summer student fellow Mika Mustafayev explains the concept of information laundering and how we can identify laundered claims – before they become news.

Read the whole thing: https://qorvis.com/follow-the-claim-how-to-spot-information-laundering-before-it-becomes-news/

Check the comments to learn more about our initiative to examine misinformation in the media.

By Mika Mustafayev Fake news is not a new phenomenon. However, in the age of technology, false information – whether that be made-up claims or AI-generated videos – can spread like wildfire. Moreover, due to information laundering, it is getting harder and harder to verify claims and distinguish...

08/19/2026

Through every major shift of the last quarter-century, from financial crises and wars to global pandemics and changing world orders, we’ve been there, helping clients understand what’s coming next.

And as our 25th anniversary year officially comes to a close, it feels like we’re on the precipice of another major shift – perhaps the most cinematic one yet.

AI is transforming how we work and communicate. Geopolitical alliances are changing. Trade relationships and supply chains are being redrawn. And physical intelligence and real-world access matter more than ever.

Qorvis is ready.

08/14/2026

A CANDU nuclear reactor could offer America an opportunity to secure strategic bottlenecks before they become catastrophic chokepoints, generating power for data centers while producing a byproduct that both quantum computing and nuclear fusion require, explains Qorvis' Abraham Went.

He makes the case for an American CANDU reactor: it would provide a second nuclear-fuel pathway while potentially converting an existing heavy-water stockpile into electricity and strategic isotope capacity.

Is CANDU a 2030s hedge against today's bottlenecks becoming tomorrow's supply crisis?

Read more:

By Abraham Went It’s quite paradoxical that the most capable technologies in world history (AI, nuclear energy, and quantum computing) revived a three-centuries-old policy response: mercantilism. Today, national self-interest has taken precedence over global cooperation. China and the United State...

07/24/2026

Strength through unity was the message that resonated throughout the 2026 NATO Summit in Ankara. Qorvis visited the Institute for an in-depth readout of the summit and its outcomes, featuring U.S. Rep. Mike Turner of Ohio and Dr. Rebeccah Heinrichs, who directs Hudson’s Keystone Defense Initiative.

Rep. Turner discussed Syria’s participation in the summit, NATO’s collective pressure campaign against the Russian war effort, and the increasing need for NATO allies to develop resilient supply chains that do not depend on China. Overall, he highlighted the renewed importance of the transatlantic alliance in times of geopolitical instability throughout Russia and the Middle East.

Thank you to the Hudson Institute for holding this event and bringing the high-level discussions of the summit back into the practical world of American business and politics.

07/24/2026

As tensions in the Strait of Hormuz continue to swell, Qorvis Senior Advisor and former Royal Navy Commander Tom Sharpe OBE spoke with Alice Hancock at the Financial Times to add perspective about the situation in the Gulf.

Despite U.S. efforts to provide air coverage to ships, Iran is still capable of making a wave out of a ripple by firing at any vessels attempting to cross the strait outside of their designated route, scaring off other potential travelers, he explained.

Sharpe and fellow experts at Qorvis remain with their ear to the ground on issues in the Middle East and beyond, providing analysis that keeps our clients ahead of the curve.

Read the article:

Renewed air campaign has yet to reassure shipowners the waterway can be made safe from Iranian attacks

07/08/2026

What makes Switzerland a global biotech powerhouse?

At BIO 2026, Qorvis Director of Business Development Casey Flores caught up with the Swiss Biotech Association to discuss what’s behind Switzerland's success, from scientific excellence and investment, to collaboration between startups, universities, and global pharmaceutical companies.

With our Geneva hub and longstanding partnerships across Switzerland's public and private sectors, these conversations are always a highlight of the BIO International Convention.

07/03/2026

A highlight of the Qorvis calendar is celebrating Independence Day with clients, colleagues, and partners in Switzerland with an all-American barbecue at the U.S. Mission Geneva, and elegant evening at the U.S. Embassy in Bern.

It was a pleasure to connect with Ambassador Callista Gingrich, former Speaker of the House Newt Gingrich, Swiss State Secretary Alexandre Fasel, and the dedicated staff at the Embassy and Mission.

This year was especially memorable as we celebrated America's 250th and the shared spirit of freedom and democracy that has long united the United States and Switzerland. As Ambassador Gingrich put it, freedom and prosperity are mutually reinforcing, a principle reflected in the enduring partnership between Switzerland and the United States.

07/01/2026

As the 2026 BIO International Convention got underway, Insilico Medicine – the generative AI-driven drug discovery company based in Boston and Hong Kong – announced a deal with Korea's SK Biopharmaceuticals worth up to $2.5 BILLION to discover new neuroimmune therapies.

The announcement set the tone for a week focused not only on scientific innovation, but also the investment, partnerships, and dealmaking needed to bring new treatments to patients around the world.

Qorvis Director of Business Development Casey Flores was on the ground meeting with some of the more than 20,000 attendees, exploring new technology on the show floor, and gathering intelligence on the policy, business, and scientific trends shaping the biotechnology industry.

For companies considering investment, manufacturing, or expansion in the United States – or looking to partner globally to advance clinical trials and new therapies – BIO remains one of the most important gatherings of the year.